What is one responsibility of the Patent Medicines Prices Review Board (PMPRB)?

The Patent Medicines Prices Review Board (PMPRB) has the responsibility to enforce price regulations on patented drugs in Canada. This is fundamental to its mandate, as the PMPRB aims to ensure that the prices of patented medicines are not excessively high, thus safeguarding public access to necessary medications. The Board reviews prices to make sure they are aligned with the price of similar drugs in other countries and to prevent excessive pricing practices.

The primary goal of the PMPRB is consumer protection and maintaining a balance in the pharmaceutical market. By enforcing regulations, the Board helps to ensure that patients and the healthcare system in general are not financially burdened by exorbitant drug prices.

Other roles of the PMPRB include monitoring and reporting on the prices of patented medicines, but the enforcement of price regulations is a proactive measure that directly affects what consumers pay for their medications. These responsibilities align with the Board's ultimate vision of ensuring affordability and equitable access to patented drugs for Canadians.